Objective: A common theme in integrative medicine (IM) is patient-centered partnering in care between patients and providers. Despite the stated ideals, few studies have assessed patients' perspectives on their actual experience in the context of a specific care model. The purpose of the present study was to retrospectively explore and compare experiences of cancer and noncancer patients under care in a consultative IM outpatient teaching clinic in the southwestern United States. Design: Qualitative study using inductive content analysis of focus group interview transcripts (2 groups of adult patients with cancers of various types and 1 group of chronically ill noncancer patients with mixed diagnoses). Method: Participants were recruited by random selection from a pool of eligible patients. Groups were conducted with patients who had completed their initial conventional cancer treatment and were at least 6 months postconsultation with an IM clinic physician. Transcripts of the audiotaped focus groups were analyzed. Results: Cancer patients (n = = 15) and noncancer patients (n = = 6) (mean age, 60 years; 77% women) expressed overall satisfaction with IM, emphasizing (1) expansion of treatment options with lower perceived toxicity than conventional therapies, (2) positive experiences of the IM physician as caring and taking time to listen, and (3) improved self-care skills and sense of empowerment. Cancer patients noted positive relationships with their conventional MDs more than did noncancer patients, although both groups appreciated the IM physicians' communication styles. Conclusion: Patients experience a consultative integrative clinic model overall as favorable. The impact on outcomes, costs, and long-term quality of life requires additional study.
Integrative medicine (IM), an emergent clinical field, is a meta-system of care. 1 Most conceptual definitions of IM claim that this field blends the "best" of conventional or mainstream medicine with complementary and alternative medicine (CAM) dependent on the needs of the patient. [2] [3] [4] [5] [6] At its highest conceptual ideal, IM refocuses the practice of medicine to healing-oriented care, wherein providers partner with patients to promote health and prevent disease. 2, 7 At a practical level, the nature of IM varies as a function of the perspective of the stakeholders (physician and patients) and system within which the care occurs.
Many academic medical professionals in the field currently emphasize and prioritize the humanistic elements of IM over specific modalities or tools. An egalitarian patient-provider partnership, in which the physician takes a primarily educative and supportive rather than paternalistic or authoritarian role, is a key aspect in the academic definitions of IM. 8, 9 The Consortium of Academic Health Centers in Integrative Medicine, 10 for instance, defines IM as "the practice of medicine that reaffirms the importance of the relationship between practitioner and patient, focuses on the whole person, is informed by evidence, and makes use of all appropriate therapeutic approaches, healthcare professionals and disciplines to achieve optimal health and healing."
For practitioners in the community, the focal debate in IM may be the nature of the practice model by which providers of each intervention participate in the care of the same patient. Given the gaps in epistemological beliefs and practices between conventional medicine and CAM, Kaptchuk and Miller 11 advocate a pluralistic option as opposed to full integration as the most pragmatic and ethical way to blend the 2 larger worlds of care. Boon et al 2 suggest a more refined range of possibilities for team care of patients that include parallel, consultative, collaborative, coordinated, multidisciplinary, interdisciplinary, and integrative models of care.
Boon et al 2 proposed that these models can be aligned along a continuum from nonintegrative to fully integrative care. Differences between the models are based on the conceptualization and operationalization of philosophy, structure, process, and outcomes. As the model of care becomes more integrated, there is greater emphasis on whole-person health with less focus on the biomedical model, less reliance on a hierarchical team structure, greater belief in the value of true patient-provider partnering and equality, and a greater focus on long-term, patient-centered outcomes.
In a preliminary report of a survey of Canadian medical doctors (n = 85) and CAM practitioners (n = 457), Moritz et al found that a collaborative model involving joint decisions and mutual respect was most acceptable overall. Notably, the MDs preferred a supervised model as a second choice, in which CAM therapies are provided via medical referral and under medical supervision. In contrast, CAM providers chose an independent practice model without medical supervision or collaboration as their second choice model. Thus, even clinicians in the health care field have not as yet resolved whether or how they might integrate their services. 12 While studies have described provider preferences and responses to these varied practice models, few have explored the patient's experiences with IM as provided under any of the proposed care models. Previous studies have explored only to a limited extent the prioritization of reasons that patients use in selecting IM. [13] [14] [15] [16] [17] Patients apparently combine conventional medical and CAM approaches rather than use one or the other exclusively, 18 without necessarily informing their physicians or CAM providers of the specific interventions that they use. This often results in a noncoordinated and independent default form of self-care, 19, 20 which creates a relative "parallel practice" approach.
Cancer patients, in particular, report substantial CAM use for both treatment of the cancer per se and as adjunctive treatment for sequelae of the disease and its conventional treatment (eg, radiation, chemotherapy, surgery). 16, [21] [22] [23] [24] [25] Yet, only 2 studies that focus on the outcomes associated with 2 IM practice models have been reported in the literature. Mulkins and Verhoef 26 described the healing experiences of 11 patients with cancer who received care in 3 different IM practices characterized as multidisciplinary. They stated that patients "became more aware of who they are and how they relate to the world" and described how patients moved through an evolutionary, transformative process of change that produced a shift in well-being and a changed worldview. They also described the experience of care, stating that patients felt that they had access to a range of supportive therapies, received care focused on overall well-being, were empowered in their cancer care decisions, and developed positive healing relationships with their providers in which they felt known, respected, and listened to. Hui et al 27 described a patient-centered approach, integrating traditional Chinese medicine with Western biomedical approaches for the treatment of cancer. Case studies were used to illustrate outcomes of their IM model of care, noting that the patients had decreased symptoms from chemotherapy, decreased use of medications, and improved well-being.
As noted by Boon et al, 3 it is important to identify and describe provider and patient experiences within the different models of IM practice. It is critical to begin to link the model of practice with particular patient populations and needs so that we can begin to develop and test hypotheses about which model might be most beneficial and yield positive patient outcomes in specific patient situations. 3, 28, 29 Therefore, the purpose of this study was to use qualitative methods to examine the experiences and responses of cancer patients to care and treatment within a consultative IM practice model and to compare these experiences to those of other chronically ill patients.
Methods
An exploratory qualitative approach was used to identify and describe experiences of patients with cancer in a consultative IM clinic. To assess the extent to which the answers to these questions generalized beyond the patients' primary cancer diagnosis, a small cohort of randomly selected noncancer patients were asked the same set of questions. Responses provided by the cancer and noncancer patients were then compared, and data were analyzed using content analytic methods.
Setting
Since its inception in 1996, the Program in Integrative Medicine (PIM) at the University of Arizona's College of Medicine in Tucson has been one of the leading academic programs in IM worldwide. The PIM focuses on integrative approaches to health care, including both allopathic and CAM intervention strategies to address health problems. A large component of the program aims to provide comprehensive training of physicians and other health care professionals in IM. A detailed description of these educational efforts and of IM is provided elsewhere. 8, 9 The present study was based on patients seen in the PIM outpatient teaching clinic. This unique IM consultative clinic in the Department of Medicine serves patients with various health concerns, as well as patients who seek health-related education and prevention. The clinic models integration of CAM with conventional medicine both diagnostically and therapeutically.
Patients who come to the clinic are seen by physicians trained in both conventional Western medicine and IM. Their cases are then presented in a weekly patient conference to a multidisciplinary group of allopathic and CAM practitioners representing various approaches, including traditional Chinese medicine, homeopathy, mind-body medicine, manipulative medicine, nutrition, naturopathy, and spirituality. This highly enriched interaction results in the formation of physician-developed individualized treatment plans that heavily emphasize integration between CAM and conventional medicine. The proposed treatment plans are then presented to and discussed with the patients as a means to invite them to take an active role in their care. The clinic provides certain CAM services to the patients, either from the IM physicians themselves (such as mind-body interventions) or from accredited non-MD (eg, Chinese medicine) CAM practitioners. Patients also receive recommendations for and referrals to CAM services from specific MD and non-MD practitioners in their local community. In the PIM teaching clinic model, the physicians thus serve as consultants to the patient over a limited series of visits but do not assume a long-term primary care role. Follow-up interactions between the PIM IM doctors and the community CAM providers can vary in number and intensity.
Participants
Approximately one third of all patients seen in the PIM clinic have or had cancer as their primary diagnosis. This cohort of patients served as the subject pool for the present study. Inclusion criteria were (1) enrollment in the PIM clinic; (2) females and males, ages 18 years or older; (3) a physician-confirmed diagnosis of cancer regardless of type, location, and staging; (4) at least 6 months postcancer therapy or history of having refused such therapy; (5) at least 6 months postinitial visit to the PIM clinic; (6) intact cognition; (7) willingness and ability to participate in the study; and (8) adequate ability to communicate in English.
Newly diagnosed patients and patients who were receiving active cancer treatments while the study was conducted were excluded to avoid introducing additional confusion or stress during conventional care by raising new therapeutic options in the course of the focus group discussions. Inclusion and exclusion criteria for the small cohort of the noncancer group were the same as above with the exception of criterion 3. The University of Arizona Institutional Review Board approved all study protocols, and all participants signed a written informed consent form. To ensure independence of data, the funding agency, a nonprofit nongovernmental private foundation, had no influence on data collection, analysis, or article preparation.
Potential participants were identified from the PIM clinic patients' outcome database based on cancerrelated ICD-9 codes. To ensure selection of a representative cohort, a randomly generated scheme was applied to select about 25 participants from the larger pool of all eligible patients. Patients were then invited by telephone and mail to participate in a 2-hour focus group. Patients were told that the purpose of the focus groups was to help the investigators better understand patients' experiences with the PIM clinic, their oncologist, and community-based non-MD CAM practitioners. Interested individuals were offered $25 for their participation. The identities of these participants were protected throughout the research. Participant quotations indicate the group number and interview number to ensure confidentiality as well as credibility of the results.
Data Collection
Focus groups were conducted with 2 different sets of cancer patients and, as a comparison, with 1 group of noncancer patients. The procedures followed Krueger's widely used research recommendations for the conduct of focus groups. 30 Group facilitators were 2 experienced researchers (LF and VC). All groups were audiotaped and later transcribed. Field notes taken by a third researcher (OC) were used only when the audiotape was not audible, a situation that occurred only once, that is, during the first 5 minutes of the first group.
Questions and language used in conduct of the focus groups were intentionally open-ended, broad, and nondirective. The facilitators did not provide any biasing information or suggestions as to the types of experiences that one might expect from the IM practice setting or changes or outcomes observed following treatment. Instead, the goal was to encourage participants to generate responses based on (1) their own personal experiences with different health care delivery systems, (2) their own interactions with different health care providers, and (3) their perceptions of outcomes and responses resulting from adopting an integrative approach to health and disease. Table 1 provides examples of the questions used during the focus groups.
Data Analysis
Inductive content analysis was used as the primary method to analyze the data collected in response to questions posed in the 3 focus groups. This method, as developed within the social sciences and linguistics, involves the process of inductive data reduction to distill the most important or essential domains of the patient experience from the words of the participants. 31 Rather than try to fit the responses into preconceived categories developed by the researchers, inductive content analysis allows categories to "emerge" from the perspective of the participants. This characteristic of inductive content analysis is particularly helpful because, as emphasized above, the primary goal of this study was to explore and compare various patients' perceptions and experiences when receiving multifaceted packages of care from different providers in various health care delivery settings⎯the PIM clinic, a traditional conventional setting, and community-based CAM practices.
Words and word phrases related to each of the research questions were identified from the transcribed data. These data units were first identified using participants' phrases, then subsequently reduced to abstract-theoretical codes by combining similarly stated coded categories. Once the abstract coding units were identified, data were again reduced and categories developed to reflect broadly the responses to the main exploratory research questions.
Frequency data provided the number of statements per category. The χ 2 statistic was used to analyze categorical variables, including demographics and differences in proportions of response categories. The quantitative analyses were performed with SPSS version 10.0, with significance set at P < .05 (Fisher exact test, 2-tailed) where relevant.
As recommended in the qualitative research literature, several methods were used to ensure scientific rigor or trustworthiness during the qualitative data analysis process. The use of a research team, periodic team conferences during data analysis and interpretation, and confirmation of the emergent categories with others (both patients and providers) who had participated in the IM clinic all strengthened the credibility of the study results. 32 The use of a research team and retrievable documents, memos, and decisional matrices created an audit or decision trail that augmented the dependability of the study results. 33 Confirmability was ensured through extensive discussions by the research team during data analysis and examination of the findings with clinic providers and meetings with clinic patients during the confirmatory stage of data analysis.
Results

Participant Characteristics
Fifteen cancer patients and 6 noncancer patients participated in the focus groups. All patients were white and ranged between 47 to 80 years of age (mean, 60 years). All participants were well educated⎯62% had at least 1 college degree. More than half of the participants had annual incomes of more than $60,000. Seventy-one percent were married, and 77% were female. Participants suffered from 8 different cancer diagnoses at various stages: 4 had breast cancers, 3 had prostate cancers, 3 had colon cancers, and 1 each had a thyroid cancer, melanoma, a brain tumor, lymphoma, or multiple myeloma. The noncancer participants suffered from diverse diagnoses including cardiovascular diseases, autoimmune disorders, and chronic musculoskeletal conditions.
Reasons for Seeking Integrative Health Care
Participants from both the cancer and noncancer groups identified that they sought integrative health care for 2 basic reasons: (1) the failure or dislike of allopathic treatment strategies (34.2% in the cancer groups; 38.4% in the noncancer group) and (2) to identify additional solutions for problems and/or symptoms (13.2% in the cancer groups; 38.4% in the noncancer group). Participants in the cancer groups pointed to the toxic effects of chemotherapy and other medications as significant motivators in their turn to CAM. "I didn't want them to screw me up anymore. I don't do well with tamoxifen, and I was taking way too many medications" (1:476). "I was attracted to these treatments because they are natural as opposed to chemo. . . . The idea of chemo is really quite frightening" (2:447, 138). Others in the cancer group saw CAM as an alternative to surgery and other invasive procedures. "My focus was totally on alternative, noninvasive, nondestructive measures for treatment. I just couldn't do that [surgery] again" (2:476). The failures cited by participants without cancer were quite similar. Side effects and allergies to medications were described as "frightening" and "unpleasant." "I'm allergic to most of the drugs, or they have horrible side effects. I'm just tired of treating the symptoms all the time without finding what is really the problem and correcting it" (3:117). "My brother died due to medications, and I decided I would try this [CAM] method. I'm just not happy with conventional medicine at all" (3:142). "Plain and simple⎯my body didn't like it⎯the coumadin" (3:555). Alternatively, there were participants who turned to CAM therapies because "they wanted to do everything possible" to address their particular problem. It appeared that these participants were not necessarily unhappy or disillusioned with allopathic interventions. Rather, they seemed to be led by pragmatism and saw CAM as value added⎯an additional strategy that could potentially alleviate symptoms or support the healing process. "I came to learn how to live with it [valley fever]" (3:131). "I was just so exhausted all the time . . . I thought I could try this" (3:117-131). "I called the clinic because I was looking for a help while waiting for a potential cure . . . why not try integrated medicine" (2:441). "I came because I wanted to find out about the relationship of nutrition to [sic] cancer" (1:100).
Participants with cancer also identified a third reason that they sought out CAM treatments. For 23.7% of the participants with cancer, the initial decision to attend the IM clinic was made because trusted others (family members, allopathic health care providers, or friends) recommended this type of treatment or initiated the referral. "My daughter is a health nut and wanted me to give this a try"(1:24), "My primary care physician worked with Dr Weil and referred me to the clinic" (2:213). "Got into this through my wife who reads Dr Weil" (1:92). "My oncologist referred me to the clinic" (1:213). While these participants acknowledged that they had limited personal information about IM or CAM modalities, they agreed to referral because they trusted their informant. "I have confidence in my doctors, and that's what they thought we should be doing" (1:136).
Experiences With Integrative Health Care
Participants were asked to discuss their experiences with the IM clinic, to describe both positive and negative aspects of treatment and care, how they would improve their experiences, and what outcomes or results that they have had from use of CAM modalities. Overwhelmingly, participants in both cancer (76.8% of positive statements) and noncancer (84.6% of positive statements) groups identified provider-patient partnering, wherein the provider honors the importance of the patient in the relationship, as the most significant aspect of the care they received as well as the aspect most divergent from allopathic care.
I was very impressed they not only asked us questions but listened to our questions. He answered our questions. Listen[ing] to you⎯that's the key. He obviously put all of the information that I talked about into the file⎯you know, listened to me. I was very happy with that interview. My primary doctor just dismisses me. Participants were able to consistently identify several essential "partnering" behaviors. Providers who honor the importance of the patient-provider relationship (1) listen and communicate understanding of patient and family concerns; (2) demonstrate a caring, respectful attentiveness wherein the patient feels recognized and valued; (3) take uninterrupted time with patients and families without rushing or being distracted; (4) consider the treatment effects on the person's life as a whole; (5) communicate the equality of all partners in the development of an intervention plan; and (6) take an "empowering" approach to treatment.
"I was never rushed. He was concerned about me-where I was and what I was doing" (2:248). "The doctor showed up several times when I was having the bone marrow transplant. I could see that feeling of really caring and looking at you as an individual" (1:400-402). "They called and checked on me⎯very thorough. It seemed like I was the most important person he had to see that day⎯it was very emotional. The PIM [sic] doctor was totally concerned, like my sister, listening" (2:254-257). "We spent a lot of time.
She really cared. She sat and listened-could have gone on forever. [She said] 'I'm here for you, and whenever you're through, we're through.' That's really different from other appointments where 5 minutes are scheduled for me" (1:252-259, 276). "We would talk about how things were going, how I was reacting. . . . She gave me options, guidance, and consultation, rather than orders" (2:174, 182).
It was great because of the time they spent in the first session. I have never had anyone spend that much time. I appreciated the time to ventilate [like] that. There was so much caring, the whole situation. I thought I was a person here, felt sincere and genuine interest on their part. That was nice. It was different. His doctor never asked us any of those questions. (3:164-170) Participants were also asked which of the recommended therapies they found most helpful or positive. Both cancer (24.5%) and noncancer (35.3%) groups reported that recommended nutritional supplements and botanicals were the most helpful. Other intervention strategies that both groups perceived as positive included relaxation techniques (22.6% and 11.7%); nutritional/dietary changes (18.9% and 5.9%); referrals to other CAM providers, including homeopaths, acupuncturists, chiropractors, Reiki masters, and others (13.2% and 5.4%); and mindfulness techniques (3.8% and 5.9%). Participants from the cancer groups further identified the coordination of treatments provided by the IM providers as helpful (5.7%).
Interestingly, the aspects that participants found to be most positive were also identified as the most negative when they did not occur consistently. Two participants in the cancer groups and 1 participant in the noncancer group reported that their experiences were particularly negative with regard to provider-patient partnering and relationship as well as the lack of empowering behaviors during the treatment process. Specifically cited as problematic in the cancer groups were (1) lack of communication, (2) lack of attentiveness or caring, and (3) inequality in the relationship. The lack of education or consultation about recommended treatment modalities was a negative aspect cited by participants in both groups. This was perceived by participants as a barrier to patient empowerment and informed choice.
"I was expecting something other than a laundry list with no explanation. How to do the kind of stuff that they were recommending. You need to teach people how to do that" (2:577-578). "I would have liked more communication, more information about chemo. I [needed] references to help me make [my own] decision. But, I never got a call back. Left messages, but no one called me back" (1:394, 839-841).
Participants suggested that the experience could be improved significantly with increased follow-up, communication, and educational efforts by providers.
Only participants with cancer identified specific CAM modalities that were less than helpful or acceptable. Among those were acupuncture (42.9%), relaxation (28.6%), nutritional supplements and botanicals (14.3%), and referrals to other CAM providers in the community (14.3%). Three participants identified that they "did not like needles" and therefore could not even entertain an acupuncture treatment. Furthermore, participants with cancer explained that they were "concerned" about the effects of supplements/ botanicals on allopathic cancer treatments and that gastrointestinal symptoms precluded the use of some supplements that were recommended. For several, the referrals to additional CAM providers or classes and groups that taught mind-body techniques added to the caretaking/care-seeking burden that often accompanies cancer therapies. Participants from both groups were able to identify both holistic and focused changes resulting from their IM experience. Among those most frequently identified were technique mastery, symptom improvement, lifestyle improvement, empowerment and selfaffirmation, and attitudinal/psychological change. Relaxation techniques and meditation were the 2 selfcare skills most consistently identified by participants as both helpful and mastered during their treatment program. Improvement in symptoms and decreased side effects from medications were also cited as positive outcomes resulting from participation in CAM therapies. Fatigue, activity intolerance, and gastrointestinal effects related to chemotherapeutic agents were all identified as symptoms that responded positively to CAM treatments. Participants also stated that they had a more positive attitude and outlook on life, could cope more effectively, and had more positive expectations about survival and a return to health following participation in the IM program.
"I tell myself I'm not going to get [cancer] again because I've taken mushrooms" (2:795). "I've decided that I can stop dead in the middle of anything and make it all go away. Now I can really listen to my body. My body tells my mind when I've gone too far. I've learned to listen and sit down" (2:684-686). "I've decided to become a proactive patient. I took charge of my hospitalization. I learned how to talk to doctors" (1:166-168). "Overall, I've become more tolerant of my disease" (3:544) . Some participants in the 2 cancer groups also attributed tumor or disease changes, including cancer remission or tumor size reduction, to the IM approach.
"There has been a dramatic effect on my cancer. I am now cancer free and attribute it to faith, support, attitude, and supplements" (2:484-485). "[Although] I have no basis for this, I feel that the MGN3 shrunk my tumor. The tumor was growing, but after following the program, it has shrunk. It's definitely no longer growing. I definitely have more energy" (2:690, 718-720). "I'm cancer free. All of the cancer is gone" (2:758).
Differences Between Allopathic and Integrative Care and Treatment
When asked to compare and contrast the care received by allopathic and integrative providers, participants in both groups indicated that the nature of the patientprovider relationship was the most significant difference (P < .01). Participants from the noncancer group (51.7%) described the relationship developed with the integrative physician as significantly different from what they had experienced.
"It's impressive because other doctors don't have the time to see you-to talk to you as if you were a person" (3:303). "I had to fight for that caring with the other MD" (3:338). "The PIM docs trusted the patient about things like how they were feeling, what their body was doing, and others did not" (3:443).
However, participants with cancer cited this difference less often (17.2%), explained in part by the positive relationships these participants with cancer had with their oncologists and specialty allopaths.
"All of the care from the . . . doctors has been phenomenal, including the oncologists and the dermatologists" (1:166). "My experiences [with integrative providers] have been similar to my past [experiences] with other doctors" (2:376). "I had good luck with my surgeon; I had an extremely good experience with my oncologist" (2:296, 306).
Other aspects of care that were cited as different by participants in both groups included the use of holistic techniques and approaches to healing, increased time spent with the patient and in consultation, time spent in teaching, and uninterrupted time with the provider.
"No one else ever talked about exercise and diet . . . they just never mentioned it" (3:1012, 1016). "The oncologist never did see the whole process⎯how it all fit together" (1:126) . "In the [allopathic] physician's office, I'm scheduled for 5 minutes. Every appointment at the [PIM] program never had a time limit" (1:276, 282). "I always sensed that a corporation is set up to schedule and maximize profits. It wasn't really about me, just the schedule" (2:332).
What was most striking, however, were the participants' descriptions of the contrasting communication styles of the providers and how these styles affected their own responses to the delivery of "bad news."
When the allopath was presenting bad news, he often cut the meeting short. There was never any discussion. He just said "looks like the tumor is growing again, but don't worry" and left the room. That's horrible news, horrible stuff. The cancer center told terrible stuff with no reaction. . . . The PIM doctor was completely different from this usual appointment; we could talk, and they would listen. (2:325, 332, 381) "I nicknamed my cardiologist as Mr Doom and Gloom⎯nothing ever positive" (3:450). "When I asked about questions about potential side effects or negative aspects, I was dismissed. The oncologist said 'don't worry, it won't hurt.' It's nice to get back to . . . people are individuals [sic]-doctors seeing you as an individual and answering your questions" (2:537). "The PIM doc never made fun of me [when I asked questions]; that was really night and day. They really talked to you, not at you, which is quite different from most docs. There was no respect for my being a PhD" (3:338).
Discussion
The purpose of this study was to examine the experiences and responses of patients with cancer to care and treatment within a consultative IM practice model and to compare these experiences to those of other chronically ill patients. The findings indicate that cancer and noncancer patients seen in a consultative IM outpatient clinic were equally satisfied with the nature of the care. In particular, they appreciated the expansion of treatment options with availability of CAM interventions they perceived as less toxic than conventional therapies. The positive quality of the provider-patient relationship, duration of visits, and the IM physicians' humanistic communication style were major advantages over conventional doctor-patient interactions. Interestingly, however, noncancer patients remarked on the latter issue more often than did cancer patients.
These findings are consistent with others in the literature. Hann 34 reported that cancer survivors used complementary therapies to manage stress, control side effects of treatments, and increase hope of survival. Hann also desired a "more involved" relationship with their provider yet did not report a negative experience with their conventional therapies or treatment. Similarly, Gray et al 35 reported that supportive care services and provider relationships were extremely important to patients with breast cancer. Rankin et al 36 identified doctor-patient communication as the most important aspect of psychosocial care for women with breast cancer. Therefore, IM's focus on patientcentered care and patient-provider partnering that allow for respectful interaction fulfills a critical need identified repeatedly by patients with cancer.
Complementary treatment choices were also consistent with those reported in the literature. Patients in the current study identified nutritional supplements and botanicals as the most helpful recommendations, followed by relaxation therapies, nutritional/dietary changes, and referrals to CAM practitioners, although the cancer group had more negative reactions to these therapies than the noncancer group. Hann 34 also found that vitamins, dietary supplements, and relaxation therapies were used by more than 50% of the sample, with vitamins used by 71%. Balneaves et al 37 also reported that vitamins were commonly used by breast cancer survivors, followed by meditation/relaxation.
Patients distinguished between providers and their tools, including the modalities, the practice environment, circumstances, or settings. For instance, some patients were satisfied with their relationships with their conventional providers but dissatisfied with brief visit lengths, preferring the longer periods of time allotted during IM visits. Other patients sought IM to identify more tools to treat their health concerns, and they wanted more detailed information about and guidance in use of the options suggested during the IM consultation, reporting dissatisfaction with the IM visits when information was not provided in sufficient depth. These findings corroborate what was reported from previous studies with patients who use CAM/IM approaches to care. 18 Individual differences in patient preference for information, participation in decision making, and treatment choices are paramount when communicating with and educating patients about treatment alternatives.
Outcomes identified in this study included improvement in medication side effects (fatigue, nausea, constipation and diarrhea, stomatitis), symptoms (pain, fatigue, activity intolerance), decreased stress and anxiety, and increased hope. These outcomes are consistent with those identified in the literature. 18, 34, 38 Although limited conclusions can be drawn from the outcomes data generated by this study, there is initial and preliminary support for findings reported by Mulkins and Verhoef 26 describing the process of transformation experienced by patients with cancer treated in a multidisciplinary IM clinic.
In the present study, most patients recognized and appreciated the presence⎯or noticed the absence⎯of compassion and caring from providers of both conventional and IM approaches. Both the psychotherapy and medical-nursing research literatures similarly report that a positive alliance between patient and provider fosters better treatment adherence and clinical outcomes. [39] [40] [41] When IM contributes to such a favorable alliance, it is likely that outcomes can improve, but further systematic research is required. An important question is whether the IM practitioner is adding factors beyond a humanistic, empowering relationship to the treatment program, a caring experience that another provider might otherwise provide in an optimal healing environment. 35, 42 The notable differences in emphasis between cancer and noncancer patients in the current data with regard to patient-provider relationships (17.2% vs 51.7%) suggest that cancer patients, in contrast with noncancer patients, may value elements of IM other than the supportive provider-patient relationship, for example, the possibility of learning about new options for treatment.
Although the findings from this study support the growing evidence that there are positive outcomes associated with IM in both cancer and noncancer populations and there is initial support for 1 type of consultative IM model of practice, these results must be considered with caution. The outcome findings from this study are extremely limited. The present data speak primarily to the perceived quality of care received in the consultative clinic and preliminary treatment outcomes and do not address generic outcomes (eg, death, disability), safety, or costs. 43 Only preliminary outcomes related to disease-specific outcomes and quality-of-life outcomes were identified and described in these patient focus groups. Further research is needed to examine patients' specific experiences of care, changes in their outcomes over time, and comparison of outcomes between different IM models of care, as well as comparison of outcomes resulting from allopathic and IM care providers.
In addition, the consultative model of care requires further examination. Although there is initial support for the usefulness of this model in both patient populations (cancer and noncancer, chronically ill), study participants did not comment on perceptions of collaboration, synergy, or value of combining their various health care treatment options and working with a team of providers from different conventional and CAM disciplines. The absence of such comments may derive not only from the questions posed to the focus group but also from the nature of the particular IM care model. Patients receiving consultative IM care were not followed by a centrally coordinated team of providers. Rather, patients assembled their own care in the community from the options suggested by the IM physicians. This model may favor a sense of selfempowerment in the patient more than other models of integrated health care but would not address how diverse practitioners might better work together to optimize the total package of care.
Patients also did not comment on their own role in choosing, integrating, or coordinating the different forms of practitioner-delivered care versus self-care. In view of the data showing that the majority of CAM is selfselected and/or self-administered, 19 additional research is needed to explore patient education needs both for content and mode of information delivery. What are patients seeking: caring and emotional support from a health care figure, additional options for treating or palliating symptoms of the disease or side effects of the conventional treatment, alternatives to conventional palliative treatments, or disease-modifying alternative interventions? The current data suggest that the answer may be a complex, individualized mix of goals, but more evaluation of these questions is needed, with both qualitative and quantitative methods.
Conclusions
In summary, some patients may prefer IM because of the rich emotional support provided, whereas others seek IM for increased information on options compared with conventional care. These findings raise the likelihood of individual differences in coping styles of patients, an issue that IM researchers have not as yet evaluated systematically. In the behavioral medicine literature on patients with noncancer chronic pain, Turk 44 previously reported improved outcomes by matching different individual coping styles with different types of treatment approaches. IM will require similar research on individualizing treatment plans as a function of not only modality and patient preferences but also patient coping style.
This study also reminds us that IM is an emerging discipline. Although Boon et al's papers in 2004 contributed to the conceptualization of this discipline and the way that it is practiced, further clarification of the process and outcomes of IM care is required before meaningful clinical trials and effectiveness research can be conducted. [45] [46] [47] [48] [49] [50] Early findings, including those reported here, indicate that both treatment environments and outcomes are multidimensional, multifaceted, and interactive. Thus, it is important to identify and characterize the multiple, complex factors from the patients, providers, treatment modalities, practice environments, and the dynamic interactions among them, all of which could contribute to patients' decisions to seek IM care and to various outcomes using a variety of qualitative and quantitative investigative approaches. 1, 51 The model of IM care studied in the current investigation differs from the types of consultative models implied by Boon et al. 2, 3 "Consultation" models in those papers were focused on the nature of the relationships between the health care professionals providing the different types of care (ie, consultation between health care professionals) and did not address the more direct patient consultative model of IM that was used in this study. Therefore, questions remain about the effectiveness of different consultative models. For example, how do the professional interrelationships, presence or absence of communication between providers and between providers and patient, and the quality of the multiple relationships in an IM practice affect the patient's outcome? What is the effect on the patient of disagreements concerning treatment plans between conventional, IM, and/or CAM providers? The social psychology, family and group therapy, and inpatient psychiatry literature indicate that disagreements among professionals working with the same patient can increase stress for the patient and potentially lead to poorer clinical outcomes. Conversely, a health care team, unified in working together within a mutually acceptable model toward helping the patient, may improve patient outcomes. A fully integrative, patientcentered research program cannot study the relationship of the patient and IM provider in isolation from the fuller clinical and social context in which the patient lives and receives health care.
In conclusion, the data point out the relevance of interdisciplinary research for IM that draws upon the body of the existing literature in diverse areas of conventional health care research, from primary care, nursing, and oncology to behavioral medicine and psychotherapy. In developing future programs of research in IM for people with cancer and noncancer chronic conditions, investigators will need to build upon data already available in order to generate a meaningful evidence base for the field of IM.
